Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients

Transplantation Proceedings

Volumn 37, Issue 9, 2005, Pages 3756-3759

  Bordils, A ^a,b   Sanchez Plumed, J ^a   Ramos, D ^a   Beneyto, I ^a   Mascaros V ^a   Molina, J M ^b   Cordoba, J ^b   Garcia J ^a   Cruz J M ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; GANCICLOVIR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; SYNAPTOTAGMIN; TACROLIMUS;

ANTIBODY TITER; ANTIGEN DETECTION; BLOOD ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC ACCURACY; FOLLOW UP; GRAFT REJECTION; HUMAN; INTERMETHOD COMPARISON; KIDNEY GRAFT; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SCREENING TEST; URINALYSIS; VIRUS LOAD;

ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 29544441336     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.074     Document Type: Conference Paper

References (26)

1. J.A. Fishman, R.H. Rubin Infection in organ-transplant recipients N Engl J Med 338 1998 1741
2. R.H. Rubin Cytomegalovirus in solid organ transplantation Transplant Infect Dis 3 2001 1
3. R. Schöeder, T. Michelon, I. Fagundes Cytomegalovirus disease latent and active infection rates during the first trimester after kidney transplantation Transplant Proc 36 2004 896
4. P. Ljungman, P. Griffiths, C. Paya Definitions of cytomegalovirus infection and disease in transplant recipients Clin Infect Dis 34 2002 1094
5. G. Opelz, B. Döhler, A. Ruhenstroth Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation a collaborative transplant study report Am J Transplant 4 2004 928
6. A.T. Borchers, R. Perez, G. Kaysen Role of cytomegalovirus infection in allograft rejection a review of possible mechanisms Transplant Immunol 7 1999 75
7. S. Sageda, K.P. Nordal, A. Hartman The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients Am J Transplant 2 2002 850
8. A. Humar, C. Paya, D. Pescovitz Clinical utility of Cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients Am J Transplant 4 2004 1
9. R.R. Razonable, C.V. Paya Valganciclovir for prevention and treatment of cytomegalovirus disease in immunocompromised hosts Expert Rev Anti Infect Ther 2 2004 27
10. N. Babel, L. Gabdrakhmanov, J. Juergensen Treatment of cytomegalovirus disease with valganciclovir in renal transplant recipients a single center experience Transplantation 78 2004 283
11. R. Casillo, M. Grimaldi, E. Ragone Efficacy and limitations of preemptive therapy against cytomegalovirus infections in heart transplant patients Transplant Proc 36 2004 651
12. R.R. Razonable, R.A. Brown, J. Wilson The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantification in transplant recipients with CMV disease Transplantation 73 2002 968
13. J.S. Kalpoe, A.C. Kroes, M.D. de Jong Validation of clinical application of cytomegalovirus plasma DNA load measurements and definition of treatment criteria by analysis of correlation to antigen detection J Clin Microbiol 42 2004 1498
14. P. Pancholi, F. Wu, P. Della-Latta Rapid detection of cytomegalovirus infection in transplant patients Expert Rev Mol Diagn 4 2004 231
15. I.G. Sia, J.A. Wilson, C.M. Groettum Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation J Infect Dis 181 2000 717
16. Boeckh Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR J Clin Microbiol 42 2004 1142
17. R. Schöeder, T. Michelon, I. Fagundes Comparison between RFLP-PCR and antigenemia for pp65 antigen for diagnosis of cytomegalovirus disease after kidney transplantation Transplant Proc 36 2004 891
18. U. Meyer-Koenig, M. Weidmann, G. Kirste Cytomegalovirus infection in organ-transplant recipients diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and quantitative Taqman PCR Transplantation 77 2004 1692
19. H. Piiparinen, K. Hockerstedt, C. Gronhagen-Riska Comparison of two quantitative CMV PCR tests, Cobas Amplicor CMV monitor and TaqMan assay, and pp65-antigenemia assay in the determination of viral loads from peripheral blood of organ transplant patients J Clin Virol 30 2004 258
20. C. Mengelle, C. Pasquier, L. Rostaing Quantification of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia J Clin Microbiol 41 2003 3840
21. S. Gouarin, A. Vabret, E. Gault Quantification analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay J Clin Virol 29 2004 194
22. Y. Xiao, K. Shi, X. Mao Detection of cytomegalovirus antigens and virus DNA in the peripheral blood after organ transplantation Zhonghua Shi Yan He Lin Chuang Bing Da Xue Za Zhi 13 1999 287
23. H. Li, J.S. Dummer, W.R. Estes Measurements of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients J Clin Microbiol 41 2003 187
24. T. Kouzarides, A.T. Bankier, S.C. Satchwell Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene J Virol 61 1987 125
25. J. Sambrook, E.F. Fristh, T. Manniatis Molecular cloning a laboratory manual 2nd ed. 1989 Cold Spring Harbor Laboratory Cold Spring, NY
26. M.C. Longo, M.S. Berninger, J.S. Hartley Use of Uracil DNA glycosilase to control carry-over contamination in polymerase chain reaction Gene 93 1990 125